These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 3276476

  • 1. Effects of accidental intramuscular injection on insulin absorption in IDDM.
    Frid A, Gunnarsson R, Güntner P, Linde B.
    Diabetes Care; 1988 Jan; 11(1):41-5. PubMed ID: 3276476
    [Abstract] [Full Text] [Related]

  • 2. Variation in absorption of NPH insulin due to intramuscular injection.
    Vaag A, Handberg A, Lauritzen M, Henriksen JE, Pedersen KD, Beck-Nielsen H.
    Diabetes Care; 1990 Jan; 13(1):74-6. PubMed ID: 2404719
    [Abstract] [Full Text] [Related]

  • 3. Hypoglycemia risk during exercise after intramuscular injection of insulin in thigh in IDDM.
    Frid A, Ostman J, Linde B.
    Diabetes Care; 1990 May; 13(5):473-7. PubMed ID: 2190773
    [Abstract] [Full Text] [Related]

  • 4. Influence of circulating epinephrine on absorption of subcutaneously injected insulin.
    Fernqvist E, Gunnarsson R, Linde B.
    Diabetes; 1988 Jun; 37(6):694-701. PubMed ID: 3289990
    [Abstract] [Full Text] [Related]

  • 5. Clinically important differences in insulin absorption from abdomen in IDDM.
    Frid A, Linde B.
    Diabetes Res Clin Pract; 1993 Jun; 21(2-3):137-41. PubMed ID: 8269814
    [Abstract] [Full Text] [Related]

  • 6. The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration.
    Hildebrandt P, Sestoft L, Nielsen SL.
    Diabetes Care; 1983 Jun; 6(5):459-62. PubMed ID: 6400706
    [Abstract] [Full Text] [Related]

  • 7. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.
    Mudaliar SR, Lindberg FA, Joyce M, Beerdsen P, Strange P, Lin A, Henry RR.
    Diabetes Care; 1999 Sep; 22(9):1501-6. PubMed ID: 10480516
    [Abstract] [Full Text] [Related]

  • 8. Intraregional differences in the absorption of unmodified insulin from the abdominal wall.
    Frid A, Linde B.
    Diabet Med; 1992 Apr; 9(3):236-9. PubMed ID: 1533580
    [Abstract] [Full Text] [Related]

  • 9. Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen.
    Henriksen JE, Djurhuus MS, Vaag A, Thye-Rønn P, Knudsen D, Hother-Nielsen O, Beck-Nielsen H.
    Diabetologia; 1993 Aug; 36(8):752-8. PubMed ID: 8405743
    [Abstract] [Full Text] [Related]

  • 10. Different absorption of isophane (NPH) insulin from subcutaneous and intramuscular sites suggests a need to reassess recommended insulin injection technique.
    Thow JC, Johnson AB, Fulcher G, Home PD.
    Diabet Med; 1990 Aug; 7(7):600-2. PubMed ID: 2146067
    [Abstract] [Full Text] [Related]

  • 11. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.
    Bantle JP, Neal L, Frankamp LM.
    Diabetes Care; 1993 Dec; 16(12):1592-7. PubMed ID: 8299455
    [Abstract] [Full Text] [Related]

  • 12. Absorption of NPH (isophane) insulin in resting diabetic patients: evidence for subcutaneous injection in the thigh as the preferred site.
    Henriksen JE, Vaag A, Hansen IR, Lauritzen M, Djurhuus MS, Beck-Nielsen H.
    Diabet Med; 1991 Jun; 8(5):453-7. PubMed ID: 1830531
    [Abstract] [Full Text] [Related]

  • 13. Absorption of rapid-acting insulin in obese and nonobese NIDDM patients.
    Clauson PG, Linde B.
    Diabetes Care; 1995 Jul; 18(7):986-91. PubMed ID: 7555561
    [Abstract] [Full Text] [Related]

  • 14. The subcutaneous absorption of human and bovine ultralente insulin formulations.
    Hildebrandt P, Berger A, Vølund A, Kühl C.
    Diabet Med; 1985 Sep; 2(5):355-9. PubMed ID: 2951089
    [Abstract] [Full Text] [Related]

  • 15. Absorption of radiolabelled soluble insulin in type 1 (insulin-dependent) diabetes: influence of subcutaneous blood flow and anthropometry.
    Vora JP, Burch A, Peters JR, Owens DR.
    Diabet Med; 1993 Oct; 10(8):736-43. PubMed ID: 8261756
    [Abstract] [Full Text] [Related]

  • 16. Effect of insulin-induced hypoglycaemia on absorption of unmodified insulin after subcutaneous or intramuscular injection.
    Grønlund B, Frandsen H, Lauritzen M, Nielsen SL, Madsbad S.
    Diabet Med; 1991 Jan; 8(1):13-7. PubMed ID: 1826237
    [Abstract] [Full Text] [Related]

  • 17. Intramuscular versus subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus.
    Vaag A, Pedersen KD, Lauritzen M, Hildebrandt P, Beck-Nielsen H.
    Diabet Med; 1990 May; 7(4):335-42. PubMed ID: 2140087
    [Abstract] [Full Text] [Related]

  • 18. An angled insertion technique using 6-mm needles markedly reduces the risk of intramuscular injections in children and adolescents.
    Hofman PL, Lawton SA, Peart JM, Holt JA, Jefferies CA, Robinson E, Cutfield WS.
    Diabet Med; 2007 Dec; 24(12):1400-5. PubMed ID: 18042081
    [Abstract] [Full Text] [Related]

  • 19. Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial.
    Heise T, Nosek L, Dellweg S, Zijlstra E, Præstmark KA, Kildegaard J, Nielsen G, Sparre T.
    Diabetes Obes Metab; 2014 Oct; 16(10):971-6. PubMed ID: 24720741
    [Abstract] [Full Text] [Related]

  • 20. Assessment of distance from skin surface to muscle for evaluation of the risk of inadvertent intramuscular insulin injection at potential injection sites among patients attending a tertiary care children's hospital in Sri Lanka-an observational study.
    Kodikara SKYI, Kalubowila J, Atapattu N, Warapitiya DS, Wijayabandara MDMS, Jayasekara LMDT, Arunthavanathan A, Kempitiya BCTANWMRCS, de Silva KSH, de Abrew K.
    Arch Pediatr; 2020 Jul; 27(5):244-249. PubMed ID: 32461034
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.